Investors.

Since its founding in 2008, Complix has raised a total of €26 million in funding (approximately US$30 million), including a €12 million B round in June 2013 and a €7 million Series A equity round in 2010.

The series B funding round in 2013 was co-led by new investors Edmond de Rothschild Investment Partners (France) and Gimv (Belgium) and Biotech Fund Flanders (managed by Gimv). Existing shareholders LRM, OMNES Capital, Vesalius Biocapital, Gemma Frisius Fund, TrustCapital, Vinnof, Baekeland Fund, CRP-Santé and management also participated in this round.

Our investors

investors_baekeland
investors_ca
investors_crp
investors_Rothschild
investors_GIMV
investors_trustcapital
investors_gemma
investors_lrm
investors_Omnes
investors_vesalius
investors_vinnof
Back to Top